Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Use of Cryoprotectants in Lyophilized Products

Posted on By

SOP for Use of Cryoprotectants in Lyophilized Products

Standard Operating Procedure for Use of Cryoprotectants in Lyophilized Products

1) Purpose

The purpose of this SOP is to establish the procedures for selecting and incorporating cryoprotectants into lyophilized formulations, ensuring the protection of active ingredients during the freezing and drying stages.

2) Scope

This SOP applies to all staff involved in the formulation and production of lyophilized products, including operators, formulation scientists, and QA teams.

3) Responsibilities

  • Formulation Scientists: Responsible for selecting suitable cryoprotectants.
  • Operators: Responsible for accurate incorporation of cryoprotectants as per the Batch Manufacturing Record (BMR).
  • QA: Responsible for verifying cryoprotectant use and documentation.
See also  SOP for Packaging of Lyophilized Products

4) Procedure

4.1 Selection of Cryoprotectants

Selection of cryoprotectants is based on the product’s stability and the sensitivity of the active pharmaceutical ingredient (API) during the freezing and lyophilization processes.

4.1.1 Criteria for Selection

  • 4.1.1.1 Choose cryoprotectants that are compatible with the formulation and do not interfere with the API.
  • 4.1.1.2 Typical cryoprotectants include sugars (e.g., sucrose, trehalose) and polyols (e.g., mannitol, glycerol).

4.2 Incorporation of Cryoprotectants

4.2.1 Weighing and Dispensing

  • 4.2.1.1 Weigh the cryoprotectants as specified in the BMR using calibrated equipment.
  • 4.2.1.2 Dispense the cryoprotectant into the formulation solution before the freezing step.

4.2.2 Mixing Procedure

  • 4.2.2.1 Ensure complete dissolution of the cryoprotectant by stirring or using a homogenizer if necessary.
  • 4.2.2.2 Ensure the solution
is clear with no visible particulates.

4.3 Documentation

All cryoprotectant additions, including weights and batch numbers, must be recorded in the Cryoprotectant Logbook and verified by QA.

5) Abbreviations

  • BMR: Batch Manufacturing Record
  • QA: Quality Assurance

6) Documents

  • Cryoprotectant Logbook

7) References

  • Scientific literature on the use of cryoprotectants in lyophilized products

8) SOP Version

Version 1.0

Annexure

Cryoprotectant Logbook Template

Date Cryoprotectant Name Batch No. Quantity Operator Initials QA Verification
DD/MM/YYYY Cryoprotectant Name Batch Number Quantity in grams Operator Name QA Initials
           


See also  SOP for Lyophilization of Live Attenuated Vaccines
Lyophilized Products Tags:Aseptic lyophilization process SOP, FDA guidelines for lyophilized products, Freeze-drying cycle development SOP, Lyophilized product SOP, Lyophilizer calibration SOP, Moisture content testing in lyophilized products, Pharmaceutical freeze-drying SOP, Quality control SOP for lyophilized drugs, SOP for cryoprotectants in lyophilized formulations, SOP for freeze-dried formulation optimization, SOP for handling lyophilized products, SOP for lyophilization of injectable drugs, SOP for lyophilization process in pharmaceuticals, SOP for lyophilization process validation, SOP for lyophilized antibiotics production, SOP for lyophilized product packaging, SOP for lyophilized product storage, SOP for lyophilized product vial filling, SOP for lyophilized vaccine production, SOP for lyophilizer equipment maintenance, SOP for pharmaceutical freeze-drying validation, SOP for primary drying in lyophilization, SOP for reconstitution of lyophilized drugs, SOP for secondary drying in lyophilization, SOP for stability testing of lyophilized products

Post navigation

Previous Post: SOP for Ensuring Microbial Stability in Nasal Formulations
Next Post: SOP for Preparation of Nanoemulsions

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version